Degenerative Disc Disease
Conditions
Brief summary
The registry has been designed as a prospective, observational program for patients undergoing anterior cervical discectomy and fusion (ACDF) procedures treated with TIDAL cervical interbody fusion device. The ultimate goal of the study is to aid in the development of treatment pathways and improved patient care. All patients who agree to participate in the registry will sign an informed consent form and subsequently be treated by their surgeon with the device in either an inpatient or outpatient facility.
Detailed description
The registry is design to collect data prospectively on patients undergoing spinal fusion using the TIDAL cervical interbody fusion device. Patients will be enrolled in the registry after reviewing the protocol with their health care provider and signing the informed consent. Data will be collected at recommended time points based on the standards of care of the participating sites. The registry will serve as a database in which retrospective analysis and exploratory analysis of specific research questions will be answered. Follow up visits will be defined by the treating physicians based on their standard practice. Typical clinical follow up schedules for patients undergoing this type of surgery are pre-operative and 12 months post-operative.
Interventions
DEVICETIDAL Cervical Interbody Fusion implant
Cervical interbody fusion device
Sponsors
Restor3D
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Neck and arm pain for a minimum of 6 weeks before surgery that is recalcitrant to nonoperative treatment modalities, such as physical therapy, reduced activities, and anti-inflammatory medications. * Radiographic evidence of cervical disc disease that is documented on dynamic radiographs and magnetic resonance imaging (MRI).
Exclusion criteria
* Medical condition that required medication, such as steroids or nonsteroidal anti-inflammatory medications, that could interfere with fusion. There are no restrictions on sex or ethnicity.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Oswestry Disability Index (ODI)/Neck Disability Index (NDI) Score Range 0-50 at 1 year post-operative from a pre-operative baseline | 1 year | ODI/NDI Score Range: 0-50 0-4 No disability 5-14 Mild disability 15-24 Moderate disability 25-34 Severe disability \>34 Complete disability |
| Change in VAS Pain at 1 year post-operative from a pre-operative baseline | 1 year | VAS PAIN SEVERITY SCALE ranges from 0-10. A score of zero (0) means 'no pain' and a ten (10) means 'worst imaginable pain' |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in patient reported short-form 36 (SF36) scores at 1 year post-operative from a pre-operative baseline | 1 year | Questionnaire of generic, coherent, and easily administered quality-of-life measures. |
| Rate of Successful Fusion Based on Radiological Assessment at 1 Year Post-op | 1 year | Assessment of fusion |
Countries
United States
Outcome results
None listed